Mirae Asset Global Investments
RVMD icon

Mirae Asset Global Investments’s Revolution Medicines RVMD Stock Holding History

Mirae Asset Global Investments’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.67M Sell
19,618
-1,486
-7% -$217K 0.01% 671
2026
Q1 		$2.05M Sell
21,104
-185
-0.9% -$18.7K 0.01% 740
2025
Q4 		$1.7M Buy
21,289
+14,062
+195% +$922K ﹤0.01% 814
2025
Q3 		$338K Buy
7,227
+32
+0.4% +$1.25K ﹤0.01% 1053
2025
Q2 		$265K Buy
7,195
+974
+16% +$37.4K ﹤0.01% 1019
2025
Q1 		$232K Buy
6,221
+615
+11% +$25K ﹤0.01% 1024
2024
Q4 		$248K Sell
5,606
-435
-7% -$22K ﹤0.01% 1022
2024
Q3 		$267K Buy
6,041
+1,115
+23% +$48.6K ﹤0.01% 1041
2024
Q2 		$190K Sell
4,926
-46,133
-90% -$1.72M ﹤0.01% 1054
2024
Q1 		$1.21M Sell
51,059
-29,346
-36% -$870K ﹤0.01% 1430
2023
Q4 		$2.31M Buy
80,405
+25,160
+46% +$605K ﹤0.01% 1190
2023
Q3 		$1.53M Sell
55,245
-3,654
-6% -$108K ﹤0.01% 1303
2023
Q2 		$1.57M Buy
58,899
+6,674
+13% +$164K ﹤0.01% 1334
2023
Q1 		$1.13M Buy
52,225
+17,781
+52% +$438K ﹤0.01% 1481
2022
Q4 		$820K Buy
34,444
+5,383
+19% +$114K ﹤0.01% 1603
2022
Q3 		$573K Buy
29,061
+9,245
+47% +$203K ﹤0.01% 1794
2022
Q2 		$386K Buy
+19,816
New +$386K ﹤0.01% 1870

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Mirae Asset Global Investments's RVMD Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Revolution Medicines (RVMD) stake by 7% in Q2 2026, selling an estimated $217K and leaving 19,618 shares worth $3.67M. The position accounts for 0.01% of the portfolio, ranked #671.

Mirae Asset Global Investments first reported a position in RVMD in Q2 2022 and has held it in 17 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Mirae Asset Global Investments held 19,618 shares of Revolution Medicines worth $3.67M as of Q2 2026.
  • Mirae Asset Global Investments sold 1,486 Revolution Medicines shares in Q2 2026, an estimated $217K.
  • Revolution Medicines made up 0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #671 holding.
  • Mirae Asset Global Investments first reported a position in Revolution Medicines in Q2 2022 and has held it in 17 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.